IndraLab

Statements


OTUB2 inhibits CD274. 3 / 3
| 3

reach
"Additionally, Ren et al. demonstrated that the pharmacological targeting of OTUB2 promotes PD-L1 degradation, increasing the sensitivity of tumor cells to T cells."

reach
"These results indicate that depletion of OTUB2 enhances antitumor immunity by regulating PD-L1 abundance and activating CTLs."

reach
"OTUB2 mediates ER-dependent degradation of PD-L1."